Virtus Biotech ETF (BBP)

NYSE · US Equities - Industry Sector · USA

Are the companies inside BBP undervalued?

The companies inside BBP trade 9% above what we estimate they are worth. We could give a verdict on 76% of the fund's weight: 70 holdings as reported to the SEC at 31 Jul 2026.

Where the money is: 16% in companies in the buy zone, 6% about fairly valued, 54% overvalued, 24% without a verdict.

What does BBP hold?

The ten largest holdings, with our verdict on each:

How much does the BBP fee cost?

Its expense ratio is 0.34% a year: on $10,000 held flat that is $340 over 10 years and $680 over 20.

Browse

Other US Equities - Industry Sector ETFs